These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9537044)

  • 21. Functional antigen binding by the defective B cells of CBA/N mice.
    Snippe H; Merchant B; Lizzio EF; Inman JK
    Adv Exp Med Biol; 1982; 149():91-6. PubMed ID: 6983243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adoptive transfer of transplantation tolerance in the H-2 compatible mouse system CBA/C3H. Transfer of lymphocyte subpopulations into irradiated and non-irradiated mice.
    Siegl E; Brock J; Schulze HA
    Allerg Immunol (Leipz); 1985; 31(2):109-12. PubMed ID: 3161310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A reappraisal of Mls genetics.
    Abe R; Hodes RJ
    J Immunogenet; 1988; 15(1-3):5-10. PubMed ID: 3148666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Status of T- and B-lymphocytes in long living CBA--F1 (CBA X C57BL/6) chimeras].
    Cherniakhovskaia IIu; Nesterenko VG; Filitis LN; Fontalin LN; Novikova TK
    Biull Eksp Biol Med; 1978 Aug; 86(8):197-200. PubMed ID: 28802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of tolerance against the MLs antigen in mice: no need for MLs-bearing cells.
    Lilliehöök B; Blomgren H; Jacobsson H; Andersson B
    Cell Immunol; 1977 Mar; 29(2):223-31. PubMed ID: 140765
    [No Abstract]   [Full Text] [Related]  

  • 26. Two separate mechanisms of T cell clonal anergy to Mls-1.
    Yui K; Ishida Y; Katsumata M; Komori S; Chused TM; Abe R
    J Immunol; 1993 Dec; 151(11):6062-75. PubMed ID: 8245451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Strong stimulation of CBA lymphocytes in the mixed lymphocyte interaction with cells from the H-2-indentical strain C3H.
    Lilliehöök B; Blomgren H
    Scand J Immunol; 1974; 3(5):627-35. PubMed ID: 4138633
    [No Abstract]   [Full Text] [Related]  

  • 28. Allostimulatory analysis of a newly-defined and widely-distributed Mls superantigen.
    Ryan JJ; LeJeune HB; Mond JJ; Finkelman FD
    Immunogenetics; 1991; 34(2):88-100. PubMed ID: 1714422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinct alloantigens trigger proliferative or nonproliferative T lymphocyte activation in CBA/N, CBA/J, and C3H mice.
    Giovarelli M; Landolfo S; Scher I; Forni G
    Transplantation; 1982 Mar; 33(3):260-4. PubMed ID: 7039035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-Mlsa-like effect of CBA/J anti DBA2 antibody in in vitro MLRs between Mls incompatible combinations.
    De Giorgi L; De Matos C; Matossian-Rogers A
    Immunol Lett; 1993 May; 36(2):171-8. PubMed ID: 8349313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The target minor H antigen for F1 cytotoxic T lymphocytes induced by Igh-congenic parental spleen cells is coded for by gene linked to H-2.
    Ishikawa H; Kubota E; Suzuki H; Saito K
    J Immunol; 1985 May; 134(5):2953-9. PubMed ID: 2580009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancement of the mixed lymphocyte reaction by in vivo treatment of stimulator spleen cells with anti-IgD antibody.
    Ryan JJ; Mond JJ; Finkelman FD; Scher I
    J Immunol; 1983 Jun; 130(6):2534-41. PubMed ID: 6222106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo development of cytolytic T lymphocytes (CTL) to hapten-altered self: MIs-disparate cells facilitate the response by neutralizing IL 2 inhibitor.
    Gautam SC; Hilfiker ML; Battisto JR
    J Immunol; 1983 Feb; 130(2):533-7. PubMed ID: 6217243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of Mls determinants in mice exhibiting the severe combined immunodeficiency (scid) mutation or X-linked immunodeficiency (xid) defect.
    Roberts JL; Abe R; Shores EW; Singer A
    J Immunol; 1992 Sep; 149(5):1577-82. PubMed ID: 1506683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T cell activation is not a prerequisite for peripheral tolerance induction to Mls 1a.
    Todd GT; Lukacsko TP; Fairchild RL
    Cell Immunol; 1994 Apr; 154(1):380-92. PubMed ID: 7510583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Weak graft-versus-host response of CBA lymphocytes against the H-2-identical strain C3H.
    Lilliehöök B; Blomgren H
    Scand J Immunol; 1974; 3(5):637-44. PubMed ID: 4153552
    [No Abstract]   [Full Text] [Related]  

  • 37. Studies on non-H-2 linked lymphocyte activating determinants. I. Description of the cell type bearing the Mls product.
    Ahmed A; Scher I; Smith AH; Sell KW
    J Immunogenet; 1977 Jun; 4(3):201-13. PubMed ID: 70491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soluble suppressor of T cell proliferation in primary in vitro response to murine minor histocompatibility antigens.
    Solana R; Alonso MC; de la Fuente M; Alonso A; Peña J
    Rev Esp Fisiol; 1984 Sep; 40(3):341-52. PubMed ID: 6240742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Partial tolerant state against H-2 disparate cells. No impaired specific reactivity in MLC, GVH, or antibody production.
    Jacobsson H; Lilliehöök B; Blomgren H
    Scand J Immunol; 1976; 5(8):949-54. PubMed ID: 11549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A stimulatory Mls-1 superantigen is destroyed by ultraviolet light while other Mtv-7 antigens remain intact. Significance for Mls-1 unresponsiveness.
    Dannecker G; Mecheri S; Clarke K; Dudhane A; Wang ZQ; Hoffmann MK
    J Immunol; 1992 Dec; 149(11):3463-7. PubMed ID: 1331237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.